Smart Money Alert

Biocon Limited

New PositionBlock Deal

BIOCONPharmaceuticalsMarket Cap₹60K Cr

Deal value

₹25.03 Cr

Deal price

₹385.00

6.50 L

Trade date

9 Sept 2026

Since alert−5.9%₹391.65 → ₹368.50

Nifty 50+6.7%

Societe Generale

Foreign Investor

The move

Societe Generale bought 6.5 lakh shares of Biocon Limited for ₹25.03 Cr at ₹385.00 apiece in a block deal.

About Biocon Limited

+ Follow Visit stock

A leading biotechnology company engaged in the manufacture of innovative pharmaceutical products and research services across multiple therapeutic areas. Biocon specializes in biologics, biosimilars, and small molecule drugs, serving patients in oncology, immunology, and diabetes therapeutics globally. The company operates integrated manufacturing facilities and maintains a strong commitment to developing affordable healthcare solutions for patients in emerging markets worldwide.

About Societe Generale

+ Follow Visit investor

French global investment bank with around EUR 1.6 trillion in assets. India FPI activity covers proprietary, market-making and client flows in listed Indian equities.

Get the next move the moment it happens.

Follow Societe Generale and Biocon Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.

Explore

Biocon Limited shareholders Societe Generale's portfolio All investors All stocks

🤖 We track their every move, post, interview and article. Obsessively.

⚡ Every move reaches your feed in minutes, while it still carries an edge

📊 Stake changes, bulk deals and insider trades, all tracked in one place

📰 A two-minute morning brief, so you start the day already ahead

More moves in Biocon Limited

HDFC Life Insurance

Direction, size, price and stake change for this move, with what it means for the company.

21 Oct 2026. Sign in to see this move